⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALNY News
Alnylam Pharmaceuticals, Inc.
Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
NVO
PFE
CSL
SNY
BMRN
ALNY
SANG
BE
REGN
NTLA
JNJ
ABBV
BMY
TEO
VRTX
CRSP
Longwood Healthcare Leaders to Host MIT CEO, Off-the-Record Networking and Discussion Forum, Convening Life Science Thought Leaders at MIT Koch Institute
accessnewswire.com
BIIB
ALNY
MRNA
REGN
JNJ
BEAM
IONS
Faron Pharmaceuticals Ltd: Directorate Appointment
accessnewswire.com
ACCL
ALNY
NVS
Resumen: Alnylam presentará nuevos análisis en Heart Failure 2026 que refuerzan la consistencia del perfil clínico de vutrisirán en la ATTR-CM
businesswire.com
ALNY
Riassunto: Alnylam presenterà nuove analisi all'Heart Failure 2026 sottolineando il profilo clinico di Vutrisiran nella ATTR-CM
businesswire.com
ALNY
Alnylam presentará nuevos análisis en Heart Failure 2026 que refuerzan la consistencia del perfil clínico de vutrisirán en la ATTR-CM
businesswire.com
ALNY
Alnylam présentera de nouvelles analyses lors du congrès Heart Failure 2026, soulignant le profil clinique constant du vutrisiran dans l’ATTR-CM
businesswire.com
ALNY
Alnylam präsentiert auf der „Heart Failure 2026“ neue Analysen, die das konsistente klinische Profil von Vutrisiran bei ATTR-CM unterstreichen
businesswire.com
ALNY
Samenvatting: Alnylam presenteert nieuwe analyses op Heart Failure 2026 die consistent klinisch profiel van vutrisiran bij ATTR-CM onderstrepen
businesswire.com
ALNY
Form 8-K
sec.gov
ALNY